PASITHEA THERAPEUTICS CORP (KTTA)

US70261F2020 - Common Stock

6.6  +0.1 (+1.54%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.00490.00K20.00K0.00
Cost Of Goods
N/A110.00K20.00KN/A
Gross Profit
N/A370.00K0.00N/A
Operating Expenses
15.98M12.49M4.50M40.00K
Research and Development
8.10M2.67MN/AN/A
Selling, General, and Administrative Expenses
7.88M9.82M4.51M40.00K
Operating Income
-15.98M-12.11M-4.51M-40.00K
Interest Income/Expense
415.37K0.000.00N/A
Other Income/Expense
56.25K1.90M2.33MN/A
Non Recurring Items
0.00-3.72MN/AN/A
Income Before Taxes
-15.51M-13.94M-2.17M-40.00K
Income Tax
0.000.000.000.00
Net Income
-15.96M-13.94M-2.17M-40.00K
EBITDA
-15.33M-12.08MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-13.01-0.55-0.090.00
 
Statistics
Gross Profit Margin
N/A75.51%N/AN/A
Profit Margin
N/A-2844.90%-10850.00%N/A
Operating Profit Margin
N/A-2471.43%-22550.00%N/A

All data in USD

Charts